Your browser doesn't support javascript.
loading
Low incidence and prevalence of hepatitis C in two cohorts of HIV pre-exposure prophylaxis adherence interventions in men who have sex with men in Southern California.
Hassan, Adiba; Agustin, Harold Glenn San; Burke, Leah; Kofron, Ryan; Corado, Katya; Bolan, Robert; Landovitz, Raphael J; Dubé, Michael P; Morris, Sheldon R.
Afiliação
  • Hassan A; Department of Medicine, University of California, San Diego, California, USA.
  • Agustin HGS; Department of Epidemiology, University of California Los Angeles Fielding School of Public Health, Los Angeles, California, USA.
  • Burke L; Department of Medicine, University of Southern California, Los Angeles, California, USA.
  • Kofron R; Department of Medicine, University of California, San Diego, California, USA.
  • Corado K; Department of Medicine, University of California, Los Angeles, California, USA.
  • Bolan R; Division of HIV Medicine, Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center, Torrance, California, USA.
  • Landovitz RJ; Los Angeles LGBT Center, Los Angeles, California, USA.
  • Dubé MP; Department of Medicine, University of California, Los Angeles, California, USA.
  • Morris SR; Department of Medicine, University of Southern California, Los Angeles, California, USA.
J Viral Hepat ; 29(7): 529-535, 2022 07.
Article em En | MEDLINE | ID: mdl-35357767
HIV pre-exposure prophylaxis (PrEP) has been associated with incident hepatitis C virus (HCV) infection in men who have sex with men (MSM) due to decreased condom use. We examined rates of HCV among MSM and transgender women at high-risk of HIV on PrEP in Southern California using data from two trials (NCT01761643 and NCT01781806). Five of 599 participants (0.84%, 95% CI, 0.27-1.93) had HCV antibodies detected at entry. Factors associated with HCV seropositivity included being older (p = .002) and lower education level (p < .001). HCV-positive participants had no reported cases of sexually transmitted infection (rectal, urethral or pharyngeal gonorrhoea and/or chlamydia) at entry while HCV-negative participants had a prevalence of 18% (95% CI, 15%-21%). There were no significant differences in substance use and sexual risk behaviour between HCV-positive and HCV-negative participants 1-3 months prior to entry. Among early PrEP adopters, incident HCV did not occur despite ongoing condomless intercourse. Screening intervals for HCV in MSM on PrEP should be led by a risk behaviour assessment.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Hepatite C / Profilaxia Pré-Exposição / Minorias Sexuais e de Gênero Tipo de estudo: Incidence_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: J Viral Hepat Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / Hepatite C / Profilaxia Pré-Exposição / Minorias Sexuais e de Gênero Tipo de estudo: Incidence_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Revista: J Viral Hepat Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Reino Unido